Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/12/18
End: 04/21/23
Due: 04/21/24
Phase: N/A
Priority: Normal
Start: 11/29/22
End: 12/12/24
Due: 12/12/25
Phase: N/A
Priority: Normal
Start: 06/12/18
End: 06/12/18
Due: 06/12/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Oral AMXT 1501 Dicaprate in Combination With DFMO | NCT03536728 | Aminex Therapeutics, Inc. | user2@example.com | None | 2018-06-12 | 2023-04-21 | 2024-04-21 | - | - | 2025-07-14 |
| Oral AMXT 1501 Dicaprate in Combination With IV DFMO | NCT05500508 | Aminex Therapeutics, Inc. | user2@example.com | None | 2022-11-29 | 2024-12-12 | 2025-12-12 | - | - | 2025-07-14 |
| Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers | NCT03077477 | Aminex Therapeutics, Inc. | user2@example.com | None | 2018-06-12 | 2018-06-12 | 2019-06-12 | - | - | 2025-07-14 |